This may be a similar or competitive research on red blood cells from stem cells
http://www.haematologica.org/content/early/2014/10/14/haematol.2014.108068
Isabel Dorn, Katharina Klich, Marcos J. Arauzo-Bravo, Martina Radstaak, Simon Santourlidis,
Foued Ghanjati, Teja F. Radke, Olympia E. Psathaki, Gunnar Hargus, Jan Kramer, Martin Einhaus,
Jeong B. Kim, Gesine Koegler, Peter Wernet, Hans R. Schöler, Peter Schlenke, Holm Zaehres
Peter Schlenke /Graz and Isabel Dorn
Univ. Dr. Peter Schlenke, Member of the Board of the University Clinic for Blood Group Serology and Transfusion Medicine, Medical University of Graz, has recently been awarded a prize at the 48th anniversary of the German Society for Transfusion Medicine and Immunohematology, in recognition of his outstanding and innovative research in the field of immunohematology and related disciplines Basel with the Philip Levine Award. The prize of EUR 10,000.00 is awarded for two years to the memory of Philip Levine, an American immunologist and hematologist, and an outstanding pioneer of blood serum serology. https://www.medunigraz.at/neues/detail/news/blut-grazer-spitzenforschung/
Artificial blood substitute in the center of Graz's research
For a long time, the committed scientist, who has just moved from Germany to Austria last year, and his team work on the artificial generation of red blood cells (erythrocytes) from adult, fetal and so-called inducible pluripotent stem cells. This basic-oriented research is of interest not only for a possible "artificial" blood substitute, but also serves for a better understanding of non-malignant diseases of the red blood cells (eg, sickle kinaemia, thalassemia)
Peter Schlenke and his life partner Isabel Dorn, who wants to "get going" in spring 2016 in Graz, are researching the pathophysiological connections between the haemolytic-gland and the human body, together with scientists from the Institute for Hygiene at the University of Münster (Prof. Helge Karch, Prof. Johannes Müthing) Uraemic syndrome, a feared complication of infection with enterohemorrhagic Escherichia coli, the shigatoxin of which may inhibit the formation of red blood cells (erythropoiesis).
http://www.haematologica.org/content/early/2014/10/14/haematol.2014.108068
https://www.medunigraz.at/neues/detail/news/stammzellforschung-rote-blutkoerperchen-aus-dem-labor/
presstext